RxDoctor Payments Data

Jodie Strauss, DO

Internal Medicine · South Euclid, OHNPI 1669447611

Payments from drug & device makers

$427in general payments, 2019–2025

Across 23 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$127
  • Supernus Pharmaceuticals, Inc.$48
  • Pfizer$40
  • Biohaven Pharmaceutical Holding Company Ltd.$37
  • E.r. Squibb & Sons, L.L.C.$26
  • Bausch Health US, LLC$23
  • plus $126 from 7 others

What the payments were for

  • Food & beverage$427100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$427 in reported general payments places this provider in the 60th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$26,507
Medicare patients
209
Services billed
404

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban60$64,986
TrulicityDulaglutide22$43,112
MounjaroTirzepatide31$36,361
JardianceEmpagliflozin16$21,042
JanuviaSitagliptin Phosphate12$19,012
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$10,704
Soliqua 100-33Insulin Glargine/Lixisenatide11$9,172
Rosuvastatin Calcium506$7,151
PremarinEstrogens, Conjugated13$4,609
Atorvastatin Calcium524$4,014
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,913
Amlodipine Besylate574$2,556
Losartan Potassium279$2,417
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,341
Potassium Chloride83$1,883

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$40$69,59573 claims
GSKTrelegy Ellipta$21$10,70413 claims
AbbVieSynthroid$127$1,15642 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in South Euclid

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →